| 1. |
姚一菲, 孫可欣, 鄭榮壽. 《2022全球癌癥統計報告》解讀: 中國與全球對比. 中國普外基礎與臨床雜志, 2024, 31(7): 769-780.
|
| 2. |
袁雙龍, 薛江, 牛小葉. 基因變異與乳頭狀甲狀腺癌診斷、治療及預后關系: 文獻綜述. 中國普外基礎與臨床雜志, 2024, 31(10): 1272-1280.
|
| 3. |
Castro ME, Cunha LL, Ward LS. Narrative overview of possible preventive measures for differentiated thyroid carcinomas. Heliyon, 2024, 11(1): e41284. doi: 10.1016/j.heliyon.2024.e41284.
|
| 4. |
Liu P, Yu X. Lymphatic metastasis of papillary thyroid carcinoma: mechanism and clinicopathological physiology. Front Endocrinol (Lausanne), 2026, 16: 1725077. doi: 10.3389/fendo.2025.1725077.
|
| 5. |
Zhong L, Shi L, Liu X, et al. Development and validation of a prediction model for lymph node metastasis in thyroid cancer: integrating deep learning and radiomics features from intra- and peri-tumoral regions. Gland Surg, 2025, 14(7): 1272-1282.
|
| 6. |
Chen J, Hong Y, Shen H, et al. Development and validation of an explainable machine learning model for preoperative prediction of central lymph node metastasis in capsular-invasive papillary thyroid carcinoma. Medicine (Baltimore), 2025, 104(48): e46101. doi: 10.1097/MD.0000000000046101.
|
| 7. |
馬夢嬌, 王嫻, 錢曉芹. 超聲影像組學及聯合基因檢測篩選高侵襲性甲狀腺乳頭狀癌研究進展. 中國醫學影像技術, 2024, 40(7): 1100-1103.
|
| 8. |
Ringel MD, Sosa JA, Baloch Z, et al. 2025 American Thyroid Association Management Guidelines for adult patients with differentiated thyroid cancer. Thyroid, 2025, 35(8): 841-985.
|
| 9. |
Ravindhran B, Lim A, Pymer S, et al. Comparative performance of clinician and computational approaches in forecasting adverse outcomes in intermittent claudication. Ann Vasc Surg, 2025, 120: 138-145.
|
| 10. |
Lusa L, Kappenberg F, Collins GS, et al. Evaluation of changes in prediction modelling in biomedicine using systematic reviews. BMC Med Res Methodol, 2025, 25(1): 167. doi: 10.1186/s12874-025-02605-2.
|
| 11. |
Pang J, Yang M, Li J, et al. Interpretable machine learning model based on the systemic inflammation response index and ultrasound features can predict central lymph node metastasis in cN0T1-T2 papillary thyroid carcinoma. Gland Surg, 2023, 12(11): 1485-1499.
|
| 12. |
Mou Y, Han X, Li J, et al. Development and validation of a computed tomography-based radiomics nomogram for the preoperative prediction of central lymph node metastasis in papillary thyroid microcarcinoma. Acad Radiol, 2024, 31(5): 1805-1817.
|
| 13. |
Cheng F, Lin G, Chen W, et al. Non-invasive prediction of central lymph node metastasis in papillary thyroid microcarcinoma with machine learning-based CT radiomics: a multicentre study. Br J Radiol, 2026, 99(1177): 176-186.
|
| 14. |
Zhou W, Li L, Hao X, et al. Predicting central lymph node metastasis in papillary thyroid microcarcinoma: a breakthrough with interpretable machine learning. Front Endocrinol (Lausanne), 2025, 16: 1537386. doi: 10.3389/fendo.2025.1537386.
|
| 15. |
Zhou YY, Zhang YZ, Li J, et al. Preoperative prediction of lymph node metastasis risk in papillary thyroid carcinoma based on multiple model comparisons. Sci Rep, 2025, 15(1): 35313. doi: 10.1038/s41598-025-19345-4.
|
| 16. |
Zou Y, Shi Y, Liu J, et al. A comparative analysis of six machine learning models based on ultrasound to distinguish the possibility of central cervical lymph node metastasis in patients with papillary thyroid carcinoma. Front Oncol, 2021, 11: 656127. doi: 10.3389/fonc.2021.656127.
|
| 17. |
Yuan J, Zhao G, Du J, et al. To identify predictors of central lymph node metastasis in patients with clinically node-negative conventional papillary thyroid carcinoma. Int J Endocrinol, 2016, 2016: 6109218. doi: 10.1155/2016/6109218.
|
| 18. |
Zhou SL, Guo YP, Zhang L, et al. Predicting factors of central lymph node metastasis and BRAFV600E mutation in Chinese population with papillary thyroid carcinoma. World J Surg Oncol, 2021, 19(1): 211. doi: 10.1186/s12957-021-02326-y.
|
| 19. |
胡曉萌, 喬宇, 韓朵蘭, 等. 甲狀腺乳頭狀癌頸部淋巴結轉移的危險因素. 中國腫瘤臨床, 2019, 46(11): 557-561.
|
| 20. |
武亞運, 章凱, 曹治敏, 等. PTC患者頸部中央區及側區淋巴結轉移危險因素分析. 中國普外基礎與臨床雜志, 2025, 32(6): 769-774.
|
| 21. |
Ji Y, Heng Y, Wang Z, et al. Risk stratification for central lymph node metastasis in mono-focal papillary thyroid carcinoma patients with encapsulated tumor as confirmed by preoperative ultrasound: a multi-center analysis. Endocrine, 2024, 86(3): 1045-1054.
|
| 22. |
Tang L, Qu RW, Park J, et al. Prevalence of occult central lymph node metastasis by tumor size in papillary thyroid carcinoma: a systematic review and meta-analysis. Curr Oncol, 2023, 30(8): 7335-7350.
|
| 23. |
Aydin A, Goktas Aydin S, Karci AC. Linking MPV and NLR to TI-RADS: improved predictive accuracy for thyroid malignancy. Medicine (Baltimore), 2025, 104(19): e42452. doi: 10.1097/MD.0000000000042452.
|
| 24. |
Detopoulou P, Panoutsopoulos GI, Mantoglou M, et al. Relation of mean platelet volume (MPV) with cancer: a systematic review with a focus on disease outcome on twelve types of cancer. Curr Oncol, 2023, 30(3): 3391-3420.
|
| 25. |
袁文濤, 張小林, 叢輝. 血小板調控腫瘤血管生成機制研究進展. 江蘇醫藥, 2024, 50(1): 83-87.
|
| 26. |
Wang L, Zhang L, Wang D, et al. Predicting central cervical lymph node metastasis in papillary thyroid carcinoma with Hashimoto’s thyroiditis: a practical nomogram based on retrospective study. PeerJ, 2024, 12: e17108. doi: 10.7717/peerj.17108.
|
| 27. |
Min Y, Huang Y, Wei M, et al. Preoperatively predicting the central lymph node metastasis for papillary thyroid cancer patients with Hashimoto’s thyroiditis. Front Endocrinol (Lausanne), 2021, 12: 713475. doi: 10.3389/fendo.2021.713475.
|
| 28. |
Wen X, Wang B, Jin Q, et al. Thyroid antibody status is associated with central lymph node metastases in papillary thyroid carcinoma patients with Hashimoto’s thyroiditis. Ann Surg Oncol, 2019, 26(6): 1751-1758.
|
| 29. |
Tan HL, Qin ZE, Duan SL, et al. Association of thyroid autoantibodies with aggressive characteristics of papillary thyroid cancer: a case-control study. World J Surg Oncol, 2024, 22(1): 224. doi: 10.1186/s12957-024-03501-7.
|